5-Amino-1MQ (50mg Vial)

5-Amino-1MQ is a selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied primarily in animal and laboratory models.

Preclinical research suggests NNMT inhibition may:

• Support fat metabolism
• Help preserve lean muscle mass
• Increase intracellular NAD⁺ levels
• Influence SIRT1-related metabolic pathways

Most available data is non-human. Human research is currently very limited. Information is provided for educational and scientific reference only.

Reconstitution Summary (Educational Reference)

• Vial strength: 50 mg
• Diluent: 2.0 mL bacteriostatic water
• Final concentration after reconstitution:

• “Reconstitution” is a fancy word that just means:

  Mixing powder with water so it becomes liquid

  In research settings:

  • Scientists add special clean water (BACwater) to the vial
  • The powder slowly melts into the water
  • They wait a bit so it mixes evenly

Concentration

• 50 mg ÷ 2.0 mL = 25 mg/mL

Commonly Referenced Preclinical Dose Range

• 2.5–5 mg
• Administered once or twice daily
• Subcutaneous route is commonly referenced in research discussions
• Lower doses are typically referenced first, with gradual increases over time

U-100 Syringe Dose Math (Key Answer)

A U-100 insulin syringe = 100 units per 1.0 mL

With a 25 mg/mL concentration:

2 mg dose calculation

• Volume needed:
  2 mg ÷ 25 mg/mL = 0.08 mL
• U-100 syringe units:
  0.08 mL × 100 = 8 units

2 mg = 8 units on a U-100 syringe